Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior
Vigneshwari Easwar Kumar, R Nambiar, Cristabelle De Souza, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1403-1403
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Advanced drug delivery platforms target cancer stem cells
MirAhmad Mazloomi, Abolfazl Doustmihan, Sajjad Alimohammadvand, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101036-101036
Open Access | Times Cited: 3
Redox signaling in drug-tolerant persister cells as an emerging therapeutic target
Zhe Zhang, Yunhan Tan, Canhua Huang, et al.
EBioMedicine (2023) Vol. 89, pp. 104483-104483
Open Access | Times Cited: 36
Cancer stem cells and their niche in cancer progression and therapy
Qiuping Liu, Zongliang Guo, Guoyin Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?
Ravichandran Vishwa, Bandari BharathwajChetty, Sosmitha Girisa, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 293-319
Open Access | Times Cited: 14
The hidden messengers: cancer associated fibroblasts—derived exosomal miRNAs as key regulators of cancer malignancy
Zixuan Gou, Jiannan Li, Jianming Liu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
Self-Renewal and Pluripotency in Osteosarcoma Stem Cells’ Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers
Sara R. Martins‐Neves, Gabriela Sampaio-Ribeiro, Célia Gomes
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8401-8401
Open Access | Times Cited: 19
BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial
John Hilton, Mihaela Cristea, Sophie Postel‐Vinay, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4079-4079
Open Access | Times Cited: 26
Natural products as drug candidates for breast cancer (Review)
Nitin Telang
Oncology Letters (2023) Vol. 26, Iss. 2
Open Access | Times Cited: 15
Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked?
Homa Fatma, Hifzur R. Siddique
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 423-440
Closed Access | Times Cited: 14
UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
Yanjing Guo, Xinyu Chen, Xiaowei Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
New insights into Notch signaling as a crucial pathway of pancreatic cancer stem cell behavior by chrysin-polylactic acid-based nanocomposite
Eman M. Ragab, Doaa M. El Gamal, Fares F. Elnajjar, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Epigenetic regulation of reprogramming and pluripotency: insights from histone modifications and their implications for cancer stem cell therapies
Wooli Bae, Eun A., Myon‐Hee Lee
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Effects of 5-azacytidine and N6-methyladenosine combination on apoptosis and stemness in human breast cancer stem cells
Günel Mukhtarova, Mesude Angın, Ayşe Caner, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Role of epigenetics in paediatric cancer pathogenesis & drug resistance
Jia Yu Leung, Hsin Yao Chiu, Reshma Taneja
British Journal of Cancer (2025)
Closed Access
Natural Bioactive Agents: Testable Stem Cell-Targeting Alternatives for Therapy-Resistant Breast Cancer
Nitin Telang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2529-2529
Open Access
Unveiling the future of cancer stem cell therapy: a narrative exploration of emerging innovations
Joseph Nhyira Obisi, Abike Ndidiamaka Josephine Abimbola, Oluwasegun Adesina Babaleye, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
A Reverse Engineering Approach to Optimize Chemical Synergy Between Target and Phenotype: Bridging the Cancer and Malaria Indications
Jean‐Yves Trosset
Methods in molecular biology (2025), pp. 137-151
Closed Access
Stem Cells in Cancer: From Mechanisms to Therapeutic Strategies
Laurence Haddadin, Xueqin Sun
Cells (2025) Vol. 14, Iss. 7, pp. 538-538
Open Access
Targeting epigenetic alterations in cancer stem cells
Francesco Verona, Vincenzo Davide Pantina, Chiara Modica, et al.
Frontiers in Molecular Medicine (2022) Vol. 2
Open Access | Times Cited: 14
Update on the Molecular Pathology of Cutaneous Squamous Cell Carcinoma
Elena-Codruța Cozma, Laura Mădălina Banciu, Cristina Soare, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6646-6646
Open Access | Times Cited: 7
Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
Catharina Muylaert, Lien Ann Van Hemelrijck, Anke Maes, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Role of Vitamin C in Targeting Cancer Stem Cells and Cellular Plasticity
Yool Lee
Cancers (2023) Vol. 15, Iss. 23, pp. 5657-5657
Open Access | Times Cited: 5
Stem Cell Models for Breast and Colon Cancer: Experimental Approach for Drug Discovery
Nitin Telang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9223-9223
Open Access | Times Cited: 8
Loss of NSUN6 inhibits osteosarcoma progression by downregulating EEF1A2 expression and activation of Akt/mTOR signaling pathway via m5C methylation
Sang Hu, Min Yang, Kang-Wen Xiao, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 4
Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top